Covaxin to be evaluated as COVID-19 vaccine candidate in US: Bharat Biotech

Covaxin has already been granted Emergency Use Listing (EUL) in 13 countries as on January 31 according to the WHO. Covaxin was granted EUL by the national regulator, Drugs Controller General of India (DCGI), in the age group 12 to 18 years on December 24, 2021.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rGxzpDs
via IFTTT